Experience
Rosellini Scientific, LLC
Grunenthal GmbH
Successfully represented Grünenthal GmbH (patentee) before the PTAB against a challenge by Rosellini Scientific, LLC involving the FDA marketed products Nucynta® and Nucynta® ER, resulting in the PTAB denying institution of IPR.
Rosellini Scientific, LLC v. Grunenthal GmbH, IPR2016-00471, PTAB, Judges Hulse, Scheiner, Yang
Grünenthal GmbH et al. v. Actavis Elizabeth LLC et al.
Grünenthal GmbH
Grünenthal GmbH v. Teva Pharmaceuticals
Grünenthal GmbH
CSL Behring GmbH v. Shire ViroPharma Inc.
CSL Behring GmbH
Grünenthal GmbH et al. v. Alvogen Pine Brook, Inc. et al.
Grünenthal GmbH et al.
Travelers Indemnity Company v. Integrated Claims Systems, LLC
The Travelers Indemnity Company
South-Tek Systems, LLC v. Engineered Corrosion Solutions, LLC
Engineered Corrosion Solutions, LLC
NXP USA, Inc. v. NFC Technology, LLC
NFC Technology, LLC
LG Electronics, Inc. et al. v. Cellular Communications Equipment LLC
LG Electronics, Inc. et al.
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.